Pangenomic Health Inc. NARA
CNSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -0.91% | 1.55% | |||
| Gross Profit | 0.91% | -1.55% | |||
| SG&A Expenses | -40.81% | 18.86% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -38.78% | 17.84% | |||
| Operating Income | 38.78% | -17.84% | |||
| Income Before Tax | 26.64% | -8.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 26.64% | -8.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 26.64% | -8.00% | |||
| EBIT | 38.78% | -17.84% | |||
| EBITDA | 38.78% | -17.84% | |||
| EPS Basic | 26.89% | -9.09% | |||
| Normalized Basic EPS | 26.67% | -9.27% | |||
| EPS Diluted | 26.89% | -9.09% | |||
| Normalized Diluted EPS | 26.67% | -9.27% | |||
| Average Basic Shares Outstanding | 0.00% | -0.85% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||